SMTI · Sanara MedTech Inc.
Market Cap
$322.22M
Shares
9.19M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$35.07
Open$34.98
Day$34.94–35.13
52W close$16.34–35.11
Avg vol 30d299K
Short int280K · 3.1% float · 1.0d
Short vol40%
Last earningsMay 12, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 11
Up next
filed Aug 11, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$109.81M
Trailing 12 months
Net income (TTM)
−$32.01M
Trailing 12 months
Revenue growth YoY
+9.0%
Year over year
Operating margin
7.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
1.4%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-3.0%
Year over year · fewer shares
Price change (1Y)
+1.2%
Trailing year
Short interest
3.1%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
High
Market backdrop
VIX 14.8 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+47%
above
Price vs 50-day avg
+10%
above
RSI (14)
74
overbought
MACD trend
Negative
52-week position
100%
near high
Momentum
relative strength
1-month return
+2%
trailing
6-month return
+107%
trailing
YTD return
+50%
this year
Relative strength
+87%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $32 › 200d $24 — 50d above 200d
Institutional flow
Accumulating
+12% holders QoQ · +14 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.05% of float · ▲ +32.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
74 holders — near 3-yr high, broad support
Squeeze score
63
elevated · 0–100
Fundamentals
Revenue growth
+32%
Y/Y
Gross margin
613%
contracting
EPS growth
−282%
Y/Y
Free cash flow
$2.2M
Balance sheet
$29.4M
net debt
Quant / Vol
risk profile
Volatility
60%
annualized · 1-yr
Max drawdown
−53%
past year
ATR
1.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 11, 2026
Net revenue
· full year 2026
Initiated
$116M – $121M
prior FY $103.12M
midpoint +14.9% Y/Y
Prior guidance
period ended
· from the 8-K filed May 11, 2026
Net revenue
· second quarter of 2026
$28.5M – $29.5M
Guided vs delivered
· last 1 settled
Net revenue
second quarter of 2026
guided $28.5M – $29.5M
$28.14M
Miss −3.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+47%
Bullish
Price vs 50-day avg
+10%
Bullish
RSI (14)
74
Bearish
MACD trend
Negative
Bearish
52-week position
100%
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $32 › 200d $24 — 50d above 200d
Institutional flow
Accumulating
+12% holders QoQ · +14 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.05% of float · ▲ +32.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
74 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $16
Now $35 · 100%
Range high $35
vs 200-day avg +47%
vs 50-day avg +10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SMTI
this stock
Sanara MedTech Inc.
|
$322.22M | +50.2% | +32.5% | — | 3.1% |
|
ISRG
Intuitive Surgical Inc
|
$137.70B | -30.6% | +20.5% | 44.8 | 2.2% |
|
BDX
Becton Dickinson & Co
|
$50.64B | — | +8.2% | — | 3.9% |
|
MDLN
Medline Inc.
|
$41.60B | -24.7% | +11.5% | — | 3.0% |
|
ALC
Alcon Inc
|
$32.76B | -17.5% | +10.5% | — | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SMTI | +0.4% | +2.4% | +106.8% | +0.5% | +50.2% |
| SPY | -0.3% | -0.1% | +20.1% | -0.7% | +11.7% |
| vs SPY | +0.8% | +2.5% | +86.7% | +1.2% | +38.5% |